MVision AI Segmentation
Overview
MVision AI provides advanced AI-powered solutions for radiotherapy treatment planning, primarily focusing on automatic segmentation and dose prediction. Its flagship products, such as Contour+ and Dose+, are part of the comprehensive Guideline-Based Segmentation (GBS™) suite and the Workspace+ platform. These tools are designed to automate repetitive tasks, standardize contouring, and streamline the radiotherapy workflow, ultimately aiming to reduce treatment planning time and enhance the quality and consistency of cancer care.
The technology leverages deep learning models to generate precise 3D delineations of organs-at-risk (OARs) and lymph node areas, adhering to international consensus guidelines like ESTRO and RTOG. This automation can significantly reduce manual work for radiation oncology professionals, allowing them to focus on more complex tasks and patient-facing care. MVision AI’s solutions are clinically evaluated and designed for seamless integration with existing DICOM-compliant treatment planning systems.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered auto-segmentation (Contour+)
- AI-powered dose prediction (Dose+)
- Guideline-Based Segmentation (GBSu2122) suite
- Synthetic imaging (Image+)
- Contour assessment (Verify)
- Guideline training environment (Guide)
- Reduces manual contouring work by up to 95%
- Enhances planning consistency and reduces inter-planner variability
- Seamless integration with DICOM-compliant Treatment Planning Systems (TPS)
- Cloud-based and on-premises deployment options
Use Cases
- Radiotherapy treatment planning for various cancer types
- Automated delineation of organs-at-risk (OARs)
- Automated delineation of lymph node areas
- Personalized dose planning and optimization for radiation therapy
- Reducing treatment planning time and improving workflow efficiency
- Standardizing contouring and reducing inter-observer variability in clinics
What Physicians Need to Know
MVision AI Segmentation can significantly reduce the time spent on manual contouring, allowing more focus on patient-facing tasks and complex treatment planning. The adherence to international guidelines helps standardize contouring practices and reduce variability, which is crucial for consistent patient care. While the AI provides highly accurate initial contours, always review and make any necessary minor adjustments to ensure optimal patient-specific treatment plans. The integrated training and verification tools can be valuable for continuous professional development and quality assurance within the department.
MVision AI Segmentation is designed for seamless integration with existing radiotherapy treatment planning systems, offering both cloud-based and local deployment options to suit various IT infrastructures and data security requirements. Its vendor-neutral Workspace+ platform allows for a unified environment for various AI-powered radiotherapy tools.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing |
| Deployment | Cloud-based and On-premises (local daemon server) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Nuclear Medicine, Oncology, Radiology |
What the Web Says
MVision AI Segmentation, particularly its Contour+ product, is an AI-powered auto-segmentation tool designed to streamline radiotherapy treatment planning by automating the delineation of organs-at-risk and lymph node regions. Physicians and healthcare IT professionals generally view the solution positively, highlighting its ability to significantly reduce contouring time, enhance consistency, and standardize practices according to international guidelines. The platform also includes tools for staff training (Guide) and contour quality verification (Verify), aiming to build trust in AI-generated contours and improve overall workflow efficiency.
Overall: PositiveStrengths
- Significantly reduces contouring time, with reported time savings of up to 95% and reducing manual contouring from hours to minutes.
- Enhances consistency and standardizes contouring practices by adhering to international guidelines (e.g., ESTRO, EPTN, RTOG).
- Reduces inter-observer variability among clinicians.
- High quality and accuracy of AI-generated contours, with many requiring minor or no manual editing.
- Seamless integration with existing treatment planning systems and flexible deployment options (cloud-based or local).
- Supports staff training and competence testing through its 'Guide' product, and allows for contour comparison and quality assurance with 'Verify'.
Limitations
- Not all products or options are available in all countries.
- Some specific contouring needs, such as CBCT/PET contouring, may not be fully supported.
- Automated segmentation can be challenging for certain structures or in patients with low BMI, potentially requiring more manual review.
- Requires clinical oversight and thoughtful integration into existing systems for successful adoption.
- Pricing information is not publicly available and requires a quote from the vendor.
Based on reviews from: rtmedical.com.br, alphaxrt.com, mpo-mag.com, softwareadvice.com, thehub.io, astro.org, mvision.ai, nih.gov, capterra.co.uk, researchgate.net, voimaventures.com, slashdot.org, intellimed.ch, xrtmedical.com, viamedica.pl
Last updated: 2026-10-31
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate MVision AI Segmentation
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for MVision AI Segmentation.
CONTOUR+ | NEW LAUNCH | V 1.2.4
Frequently Asked Questions
Investors who backed MVision AI Segmentation
Funded through the company that built this tool.
